A detailed history of Bailard, Inc. transactions in Haleon PLC stock. As of the latest transaction made, Bailard, Inc. holds 21,520 shares of HLN stock, worth $206,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,520
Previous 21,470 0.23%
Holding current value
$206,376
Previous $222,000 13.06%
% of portfolio
0.0%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 30, 2025

BUY
$8.72 - $10.35 $436 - $517
50 Added 0.23%
21,520 $193,000
Q2 2025

Aug 08, 2025

SELL
$9.27 - $11.41 $14,535 - $17,890
-1,568 Reduced 6.81%
21,470 $222,000
Q1 2025

May 02, 2025

BUY
$9.02 - $10.67 $207,802 - $245,815
23,038 New
23,038 $237,000
Q3 2022

Oct 18, 2022

BUY
$5.63 - $7.5 $63,720 - $84,885
11,318 New
11,318 $69,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $44.3B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Bailard, Inc. Portfolio

Follow Bailard, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bailard, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bailard, Inc. with notifications on news.